Long Focus Capital Management, LLC Reata Pharmaceuticals Inc Transaction History

Long Focus Capital Management, LLC

  • $2.73 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$19.41 - $36.49 $252,330 - $474,370
-13,000 Reduced 56.52%
10,000 $251,000
Q1 2022

May 13, 2022
SELL
$24.12 - $39.6 $603,000 - $990,000
-25,000 Reduced 52.08%
23,000 $753,000
Q4 2021

Feb 14, 2022
BUY
$25.61 - $110.96 $1.23 Million - $5.33 Million
48,000 New
48,000 $1.27 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Long Focus Capital Management, LLC Portfolio

Follow Long Focus Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Long Focus Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Long Focus Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email